ABIOMED, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016; Provides Earnings Guidance for the Year 2017
For the nine months, the company reported revenue of $320,624,000 against $235,586,000 a year ago. Income from operations was $61,144,000 against $45,291,000 a year ago. Income before income taxes was $61,987,000 against $45,611,000 a year ago. Net income was $37,217,000 against $27,149,000 a year ago. Diluted net income per share was $0.83 against $0.61 per share a year ago.
For the year 2017, the company expects revenue guidance with the new range of $440 million to $445 million, an increase in revenue of 34% to 35% from the prior year. This compares to the prior increased forecast of $435 million to $445 million. The Company projects revenue to be around $122 million for the fourth quarter of fiscal 2017 and is maintaining its fiscal year guidance for GAAP operating margin in the range of 18% to 20%.